April 2022

 

© WHO / Jonathan Perugia

Non-stop work: protecting the world from seasonal and pandemic influenza

Interesting and informative news from our trusted teams around the world delivered to your inbox. Enjoy and feel free to share; we value every subscriber. 

 

© WHO

70 fantastic years of GISRS

GISRS is celebrating 70 years of success as a global network providing a first line of defence against influenza. Find out more on our newly published anniversary webpage.

Find out more
 

© WHO

Tracing the development of GISRS

A newly published photo story looks at how GISRS has developed over the last 70 years, as it celebrates this momentous anniversary.

Find out more
 

© WHO / Hayley Goldbach

Boosting biosafety

Through regional training, South-East Asia is helping turn guidance into practice for laboratory biosafety.

Find out more
 

© WHO

Yemen ready to ship

New training in Yemen has enhanced critical laboratory capacities for transporting specimens of infectious viruses, including influenza.

Find out more
 

© WHO / Blink Media, Hannah Reyes Morales

Influenza vaccines for health workers

WHO investigates what makes seasonal influenza vaccination programmes for health workers successful and sustainable.

Find out more
 

© WHO / Etinosa Yvonne

First time achievements in Africa and the Eastern Mediterranean

The PIP Framework has enabled significant gains to pandemic influenza preparedness in these regions, despite multiple emergencies.

Find out more
 

© WHO

Welcome Togo! New NIC joins GISRS

The influenza laboratory at the Institut National d’Hygiene (INH) has gained WHO recognition as a National Influenza Centre, joining GISRS.

Find out more
 

© WHO / Nursila Dewi

PIP progress

The PIP PC 2020–2021 biennial progress report showcases public health gains.

Find out more
 

© WHO

Guiding clinical care

WHO’s latest influenza guidelines advise clinicians on strategies for people with or at risk of severe flu.

Find out more
 

© CIDRAP

Accelerating influenza vaccine R&D

Support the Call to Action for the Influenza Vaccines R&D Roadmap, a 10-year framework for prioritizing influenza vaccine R&D.

Find out more
 

Publications

March

Guidelines for the clinical management of severe illness from influenza virus infections

February

Recommended composition of influenza virus vaccines for use in the 2022-2023 northern hemisphere influenza season

January

End-to-end integration of SARS-CoV-2 and influenza sentinel surveillance: revised interim guidance

PIP PC Preparedness High-Level Implementation Plan II 2018-2023, 2021 Revision

 
Website
 
 

General disclaimers. The designations employed and the presentation of the material in this publication do not imply the expression of any opinion whatsoever on the part of WHO concerning the legal status of any country, territory, city or area or of its authorities, or concerning the delimitation of its frontiers or boundaries. Dotted and dashed lines on maps represent approximate border lines for which there may not yet be full agreement.

 

The mention of specific companies or of certain manufacturers’ products does not imply that they are endorsed or recommended by WHO in preference to others of a similar nature that are not mentioned. Errors and omissions excepted, the names of proprietary products are distinguished by initial capital letters.

 

All reasonable precautions have been taken by WHO to verify the information contained in this publication. However, the published material is being distributed without warranty of any kind, either expressed or implied. The responsibility for the interpretation and use of the material lies with the reader. In no event shall WHO be liable for damages arising from its use.

Preferences  |  Unsubscribe